Application of CPB technology in production of Actoverco’s Interferon beta 1-a
According to Actoverco’s Public Relations, we are currently producing the raw material of interferon beta-1a from the cell line in the Actover Group in the Actoverco Biotech factory.
Dr. Sattari’s visits from Actoverco, Actoverco’s Innovation Center launch and signing two cooperation agreements
The Vice President for Science and Technology visited the production lines and various sections of this pharmaceutical complex at the Actoverco factory.
Actoverco received 90.8 million Euros of governmental currency in the first half of this year
The CEO of Actoverco said: “This Company has received about 90 million and 800 thousand Euros of governmental currency in the first 6 months of the year.”